During the past decade, Hrpc Ulbratech - Ulbra conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hrpc Ulbratech - Ulbra" are "Acute Respiratory Infection" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Hrpc Ulbratech - Ulbra" in a lesser frequency.

Most popular intervention types in "Hrpc Ulbratech - Ulbra" are "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nasal Swab Sample" (1 trials), "Pimodivir 600 mg" (1 trials), "Placebo" (1 trials) and "SOC Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hrpc Ulbratech - Ulbra" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hrpc Ulbratech - Ulbra". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hrpc Ulbratech - Ulbra, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hrpc Ulbratech - Ulbra, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".